20th Anniversary
2025 is a special year for the Graduate School of Cellular and Biomedical Sciences (GCB) as we celebrate its 20th anniversary. To mark this milestone, we organized a special program for this year’s annual research symposium on June 26, 2025.
The GCB officially opened on September 1, 2005. Since then, over 1,400 doctoral students from three faculties (Medicine, Science, and Veterinary Medicine) working in various fields of cellular and biomedical sciences have obtained an interfaculty doctorate. In the first GCB annual report published in 2007, then GCB president Prof. Daniel Schümperli stated “the expected final size of the GCB will be about 400 students.” By the end of 2024, the GCB boasted 549 registered students, clearly exceeding the 2007 predictions.The graduate school continues to grow, adding an average of 150 new students each year while approximately 120 students graduate annually. While 17 mentors supported the initial 45 students in 2005, this number has grown to 122.
The Graduate School for Cellular and Biomedical Sciences (GCB) of the University of Bern, jointly administered by the Faculties of Medicine, Science and Vetsuisse, offers structured, experimental research training programs leading to a PhD, MD,PhD, DDS,PhD or DVM,PhD degree.
The PhD program provides comprehensive, internationally competitive training in the theory and practice of experimental research as well as in-depth specialist knowledge of the individually selected research area. It directs the students towards independent scientific work and enables them to assume scientific responsibility. Research training is available in the areas of Biochemistry and Molecular Biology, Biomedical Engineering, Biomedical Sciences, Cell Biology, Immunology, Neuroscience, and Epidemiology.
Applicants should possess a Master's degree, or equivalent, in Life Sciences or related areas, Biomedical Engineering, Medicine, Dentistry, or Veterinary Medicine.
GCBVisionandMission_eng.pdf
